Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Rosenmann

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Alzheimer Research|March 29, 2013
Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathiesHanna Rosenmann
Journal of Molecular Neuroscience : MN|November 8, 2011
CSF biomarkers for amyloid and tau pathology in Alzheimer's diseaseHanna Rosenmann
Nature Medicine|November 7, 2014
Asparagine endopeptidase cleaves tau and promotes neurodegenerationHanna Rosenmann
Harefuah|January 15, 2014
[Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment]Hanna Rosenmann, Zeev Meiner
Harefuah|August 1, 2012
[Biological markers in the diagnosis of dementia and Alzheimer's disease]Zeev Meiner, Hanna Rosenmann
International Journal of Alzheimer'S Disease|August 29, 2012
Tau protein: function and pathologyHanna Rosenmann, David Blum, Rakez Kayed, et al.
Phytotherapy Research : PTR|March 18, 2011
The herbal preparation Padma® 28 protects against neurotoxicity in PC12 cellsIsaac Ginsburg, Lea Rozenstein-Tsalkovich, Erez Koren, et al.
Neuroscience Letters|November 11, 2006
Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjectsHanna Rosenmann, Zeev Meiner, Valeria Geylis, et al.
Experimental Neurology|February 13, 2018
Phos-tau peptide immunization of amyloid-tg-mice reduced non-mutant phos-tau pathology, improved cognition and reduced amyloid plaquesSandrine Benhamron, Lea Rozenstein-Tsalkovich, Keren Nitzan, et al.
Biomed Research International|March 20, 2015
Advances in Alzheimer's disease: from bench to bedsideTeng Jiang, Raymond Chuen-Chung Chang, Hanna Rosenmann, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Alzheimer Research|March 29, 2013
Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathiesHanna Rosenmann
Journal of Molecular Neuroscience : MN|November 8, 2011
CSF biomarkers for amyloid and tau pathology in Alzheimer's diseaseHanna Rosenmann
Nature Medicine|November 7, 2014
Asparagine endopeptidase cleaves tau and promotes neurodegenerationHanna Rosenmann
Harefuah|January 15, 2014
[Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment]Hanna Rosenmann, Zeev Meiner
Harefuah|August 1, 2012
[Biological markers in the diagnosis of dementia and Alzheimer's disease]Zeev Meiner, Hanna Rosenmann
International Journal of Alzheimer'S Disease|August 29, 2012
Tau protein: function and pathologyHanna Rosenmann, David Blum, Rakez Kayed, et al.
Phytotherapy Research : PTR|March 18, 2011
The herbal preparation Padma® 28 protects against neurotoxicity in PC12 cellsIsaac Ginsburg, Lea Rozenstein-Tsalkovich, Erez Koren, et al.
Neuroscience Letters|November 11, 2006
Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjectsHanna Rosenmann, Zeev Meiner, Valeria Geylis, et al.
Experimental Neurology|February 13, 2018
Phos-tau peptide immunization of amyloid-tg-mice reduced non-mutant phos-tau pathology, improved cognition and reduced amyloid plaquesSandrine Benhamron, Lea Rozenstein-Tsalkovich, Keren Nitzan, et al.
Biomed Research International|March 20, 2015
Advances in Alzheimer's disease: from bench to bedsideTeng Jiang, Raymond Chuen-Chung Chang, Hanna Rosenmann, et al.
Pageof 7